Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma.

× No keyword cloud information.

6 in total

1. Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma.

Authors: Aya Nakaya; Shinya Fujita; Atsushi Satake; Takahisa Nakanishi; Yoshiko Azuma; Yukie Tsubokura; Masaaki Hotta; Hideaki Yoshimura; Kazuyoshi Ishii; Tomoki Ito; Shosaku Nomura
Journal: Leuk Res Rep Date: 2016-06-29

2. A better prediction of progression-free survival in diffuse large B-cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV_max.

Authors: Yi-Yang Zhang; Le Song; Mei-Xin Zhao; Kai Hu
Journal: Cancer Med Date: 2019-07-25 Impact factor: 4.452

3. Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study.

Authors: Xue Shi; Xiaoqian Liu; Xiaomei Li; Yahan Li; Dongyue Lu; Xue Sun; Ying Li; Shunfeng Hu; Yuanfeng Zhang; Xiangxiang Zhou; Xin Wang; Haiping Chen; Xiaosheng Fang
Journal: Front Oncol Date: 2021-12-16 Impact factor: 6.244

4. Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.

Authors: Junshik Hong; Seok Jin Kim; Myung Hee Chang; Jeong-A Kim; Jae-Yong Kwak; Jin Seok Kim; Dok Hyun Yoon; Won Sik Lee; Young Rok Do; Hye Jin Kang; Hyeon-Seok Eom; Yong Park; Jong-Ho Won; Yeung-Chul Mun; Hyo Jung Kim; Jung Hye Kwon; Jee Hyun Kong; Sung Yong Oh; Sunah Lee; Sung Hwa Bae; Deok-Hwan Yang; Hyun Jung Jun; Ho Sup Lee; Hwan Jung Yun; Soon Il Lee; Min Kyoung Kim; Jun Ho Yi; Jae Hoon Lee; Won Seog Kim; Cheolwon Suh
Journal: Oncotarget Date: 2017-09-18

5. Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma.

Authors: Shuang Wu; Ye Zhou; Hai-Ying Hua; Yan Zhang; Wen-Yan Zhu; Zhi-Qing Wang; Jin Li; Hua-Qiang Gao; Xiao-Hong Wu; Ting-Xun Lu; Dong Hua
Journal: BMC Cancer Date: 2018-10-19 Impact factor: 4.430

6. Clinicopathological characteristics and treatment outcome in obese patients with diffuse large B-cell lymphoma.

Authors: Yu-Ying Wu; Jie-Yu You; Cih-En Huang; Chia-Chen Hsu; Yi-Yang Chen; Hsing-Yi Tsou; Ying-Ju Chen; Chian-Pei Li; Yi-Hua Lai; Chang-Hsien Lu; Ping-Tsung Chen; Chih-Cheng Chen
Journal: Transl Cancer Res Date: 2020-10 Impact factor: 1.241